Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2026-03-07 @ 4:48 AM
Study NCT ID:
NCT05737160
Status:
COMPLETED
Last Update Posted:
2025-05-23
First Post:
2023-02-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Telitacicept in Generalized Myasthenia Gravis
Sponsor:
RemeGen Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
18C029
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None